CRISIL |
Strong operating performance; upgrade to BUY |
BUY
CMP: Rs839 Target Price: Rs1050
n CRISIL’s Q3CY11 revenue came in at Rs2.1bn, inline with expectation. However net profit at Rs602mn was ahead of expectation led by lower opex and one off gains of Rs104mn
n While rating revenues remain stable qoq, Research business continues to show strong growth (7.8%qoq). Continued momentum in IREVNA & leverage on pipal bus to drive rev
n Operating margins expanded by 63bps qoq to 35% led by 165/ 41bps yoy improvement in rating and research margins
n Shifting our valuation methodology from premium to Sensex valuations to cash flow discounting. Accordingly, revising price target to Rs1050 and upgrade to BUY
Regards,
Kashyap Jhaveri |
Research Analyst | Emkay Global Financial Services Ltd. | www.emkayglobal.com | Email : kashyap...@emkayglobal.com |
Board No. : +91-22-6612 1212 | Extn. : 249 | DID : +91-22-6612 1249 | Mob : +91-98202 41712 | Fax : +91-22-6624 2410 | |
|